

[ Tue, Feb 21st 2023
] - WOPRAI

[ Wed, Feb 08th 2023
] - WOPRAI

[ Thu, Jan 19th 2023
] - WOPRAI
[ Thu, Jan 19th 2023
] - WOPRAI

[ Wed, Jan 11th 2023
] - WOPRAI

[ Mon, Dec 12th 2022
] - WOPRAI

[ Fri, Oct 14th 2022
] - WOPRAI

[ Wed, Aug 17th 2022
] - WOPRAI

[ Tue, Jul 26th 2022
] - WOPRAI
[ Tue, Jul 26th 2022
] - WOPRAI
[ Tue, Jul 26th 2022
] - WOPRAI

[ Fri, Jul 15th 2022
] - WOPRAI

[ Thu, Jun 23rd 2022
] - WOPRAI

[ Tue, May 17th 2022
] - WOPRAI

[ Wed, May 11th 2022
] - WOPRAI

[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI

[ Fri, Apr 22nd 2022
] - WOPRAI

[ Thu, Mar 31st 2022
] - WOPRAI
[ Thu, Mar 31st 2022
] - WOPRAI

[ Fri, Nov 19th 2021
] - WOPRAI
[ Fri, Nov 19th 2021
] - WOPRAI
[ Fri, Nov 19th 2021
] - WOPRAI

[ Tue, Feb 02nd 2021
] - WOPRAI

[ Mon, Jan 25th 2021
] - WOPRAI

[ Tue, Jan 05th 2021
] - WOPRAI

[ Fri, Dec 18th 2020
] - WOPRAI

[ Thu, May 07th 2020
] - WOPRAI

[ Thu, Apr 30th 2020
] - WOPRAI

[ Mon, Nov 25th 2019
] - WOPRAI

[ Thu, Nov 21st 2019
] - WOPRAI

[ Thu, May 02nd 2019
] - WOPRAI

[ Mon, Apr 15th 2019
] - WOPRAI

[ Tue, Apr 09th 2019
] - WOPRAI

[ Thu, Oct 25th 2018
] - WOPRAI

[ Tue, Oct 16th 2018
] - WOPRAI

[ Tue, Aug 28th 2018
] - WOPRAI

[ Mon, Aug 13th 2018
] - WOPRAI

[ Thu, Aug 09th 2018
] - WOPRAI

[ Fri, May 04th 2018
] - WOPRAI

[ Fri, Feb 09th 2018
] - WOPRAI

[ Thu, Feb 01st 2018
] - WOPRAI

[ Fri, Sep 22nd 2017
] - WOPRAI

[ Fri, Sep 08th 2017
] - WOPRAI

[ Mon, Apr 17th 2017
] - WOPRAI


[ Tue, Apr 12th 2016
] - WOPRAI


[ Tue, Oct 07th 2014
] - WOPRAI
Do Kim Maintained (TVTX) at Buy with Increased Target to $46 on, Feb 21st, 2023
Do Kim of Piper Sandler, Maintained "Travere Therapeutics, Inc." (TVTX) at Buy with Increased Target from $42 to $46 on, Feb 21st, 2023.
Do has made no other calls on TVTX in the last 4 months.
There are 2 other peers that have a rating on TVTX. Out of the 2 peers that are also analyzing TVTX, 1 agrees with Do's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Alex Thompson of "Stifel" Initiated at Hold and Held Target at $22 on, Wednesday, December 14th, 2022
This is the rating of the analyst that currently disagrees with Do
- Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $40 on, Monday, January 30th, 2023